Literature DB >> 8921884

Characterization of a leucine-zipper-like domain in Vpr protein of human immunodeficiency virus type 1.

L Wang1, S Mukherjee, O Narayan, L J Zhao.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) replicates productively in vitro in CD4(+)-T cells and/or macrophages. In the host, however, HIV-1 replication may be restricted by the quiescence of susceptible cells. Vpr is a 15-kDa late viral gene product, which is assembled in the virion and suspected to enhance HIV-1 replication in the infected host. We demonstrated previously that Vpr interacted specifically with the cellular transcription factor Sp1, and activated transcription from the HIV-1 long-terminal-repeat. Both Vpr-Sp1 interaction and trans-activation by Vpr required a central Leu/Ile-rich domain (LR domain, aa 60-81) in Vpr. This domain of Vpr was also found critical for Vpr interaction with another cellular protein of 180 kDa. We now provide biochemical evidence that the Vpr LR-domain has a leucine-zipper-like structure. The leucine-zipper structure has been found in a variety of cellular transcription factors, which use the leucine-zipper domain to form a specific dimer before they can bind to DNA through an upstream basic domain. The LR domain of HIV-1 Vpr, when fused to the basic domain of the cellular transcription factor CREB, was capable of supporting specific DNA binding by the CREB basic domain. Point mutational analysis of the Leu/Ile residues in the LR domain suggested that multiple Leu/Ile residues may be involved in maintaining the leucine-zipper-like structure. Mutagenesis in the context of the full-length Vpr also helped identify Leu/Ile residues may be involved in maintaining the leucine-zipper-like structure. Mutagenesis in the context of the full-length Vpr also helped identify Leu/Ile residues critical for Vpr interaction with the cellular 180-kDa protein. These results suggested that the leucine-zipper-like domain may be an important functional determinant for HIV-1 Vpr.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8921884     DOI: 10.1016/0378-1119(96)00312-5

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  15 in total

1.  Human immunodeficiency virus type 1 Vpr-mediated G(2) cell cycle arrest: Vpr interferes with cell cycle signaling cascades by interacting with the B subunit of serine/threonine protein phosphatase 2A.

Authors:  M Hrimech; X J Yao; P E Branton; E A Cohen
Journal:  EMBO J       Date:  2000-08-01       Impact factor: 11.598

2.  Rap1p requires Gcr1p and Gcr2p homodimers to activate ribosomal protein and glycolytic genes, respectively.

Authors:  S J Deminoff; G M Santangelo
Journal:  Genetics       Date:  2001-05       Impact factor: 4.562

3.  Human immunodeficiency virus type 1 Vpr contains two leucine-rich helices that mediate glucocorticoid receptor coactivation independently of its effects on G(2) cell cycle arrest.

Authors:  M P Sherman; C M de Noronha; D Pearce; W C Greene
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Activation of the ATR pathway by human immunodeficiency virus type 1 Vpr involves its direct binding to chromatin in vivo.

Authors:  Maoyi Lai; Erik S Zimmerman; Vicente Planelles; Junjie Chen
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  Nucleocytoplasmic shuttling by human immunodeficiency virus type 1 Vpr.

Authors:  M P Sherman; C M de Noronha; M I Heusch; S Greene; W C Greene
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

Review 6.  Roles of Vpr and Vpx in modulating the virus-host cell relationship.

Authors:  Vicente Planelles; Edward Barker
Journal:  Mol Aspects Med       Date:  2010-06-15

7.  Human immunodeficiency virus type 1 (HIV-1) viral protein R (Vpr) interacts with Lys-tRNA synthetase: implications for priming of HIV-1 reverse transcription.

Authors:  L A Stark; R T Hay
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

8.  The C-terminal domain of the HIV-1 regulatory protein Vpr adopts an antiparallel dimeric structure in solution via its leucine-zipper-like domain.

Authors:  Sarah Bourbigot; Hervé Beltz; Jérôme Denis; Nelly Morellet; Bernard P Roques; Yves Mély; Serge Bouaziz
Journal:  Biochem J       Date:  2005-04-15       Impact factor: 3.857

9.  HIV-1 Vpr oligomerization but not that of Gag directs the interaction between Vpr and Gag.

Authors:  Joëlle V Fritz; Denis Dujardin; Julien Godet; Pascal Didier; Jan De Mey; Jean-Luc Darlix; Yves Mély; Hugues de Rocquigny
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

10.  Cellular phenotype impacts human immunodeficiency virus type 1 viral protein R subcellular localization.

Authors:  Adriano Ferrucci; Michael R Nonnemacher; Brian Wigdahl
Journal:  Virol J       Date:  2011-08-10       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.